• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

New Delhi: Panacea Biotec will be developing a new chemical entity with Punjab University. The vaccine maker has entered into an agreement with the university for a drug discovery project. Under the agreement, the company’s drug discovery R&D centre, Laksh, at Mohali, Punjab will collaborate with the university to identify lead molecules in the therapeutic area of psychiatric disorders. Panacea will undertake the pre-clinical and clinical developments of the molecules, and launch the product worldwide. — Our Bureau

More Stories on : Research & Development | Pharmaceuticals | Education

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Panacea, Punjab varsity in pact

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line